Back to search

Netherlands· NL-ee64fa181a0f

Upstaza 2,8 x 10^11 vg/0.5 ml, oplossing voor infusie

A other nervous system drugs product containing eladocageen exuparvovec, registered in Netherlands by PTC Therapeutics International Limited. The same ATC class is registered in 3 of our 19 countries.

ATC N07

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedUpstaza 2,8 x 10^11 vg/0.5 ml, oploss…ATCN07REGISTER NO.NL-ee64fa181a0fPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Eladocageen exuparvovec is registered in 3 of 19 countries.

Countries holding a registration under ATC N07 (other nervous system drugs), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 1 of them publish a price we can compare per daily dose

Eladocageen exuparvovec · ATC N07

3 / 19 countries

  • Finlandprice
  • Ireland
  • Netherlands
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ELADOCAGEEN EXUPARVOVEC
Manufacturer
PTC Therapeutics International Limited
Country
Netherlands (NL)
ATC code
N07
ATC class
OTHER NERVOUS SYSTEM DRUGS
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/22/1653

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0ae87c6f-4fdc-4997-be39-a58c1c1e1c1b
GET /v1/drugs/0ae87c6f-4fdc-4997-be39-a58c1c1e1c1b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor infusie",
  "route": "Intracerebraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/upstaza-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Other Nervous System Drugs",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp126214",
  "excipients": [
    "DINATRIUMWATERSTOFFOSFAAT 0-WATER (E 339)",
    "KALIUMCHLORIDE (E 508)",
    "KALIUMDIWATERSTOFFOSFAAT 0-WATER (E 340)",
    "NATRIUMCHLORIDE",
    "POLOXAMEER 188",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "ELADOCAGEEN EXUPARVOVEC"
  ],
  "leaflet_url": null,
  "authorised_at": "2022/07/18",
  "procedure_number": "EMEA/H/C/005352",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/22/1653",
  "additional_monitoring": "N"
}

See everything about eladocageen exuparvovec.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.